Page last updated: 2024-09-03

fullerene c60 and Lung Diseases

fullerene c60 has been researched along with Lung Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Choi, K; Kim, H; Kim, Y; Park, EJ; Park, K; Yi, J	1
Gamo, M; Nakanishi, J; Shinohara, N	1
Chen, D; Cui, H; Kwak, G; Liu, J; Liu, S; Rao, D; Shu, C; Su, Y; Suk, JS; Wang, H; Wu, J; Zuo, X	1
Taylor, AE	1
Chen, YW; Hwang, KC; Lai, YL; Yen, CC	1
Marchione, AA; Reed, KL; Sayes, CM; Warheit, DB	1

Reviews

1 review(s) available for fullerene c60 and Lung Diseases

Article	Year
Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 123, Issue:2 Topics: Animals; Dose-Response Relationship, Drug; Fullerenes; Humans; Inhalation Exposure; Intubation, Intratracheal; Lung; Lung Diseases; Maximum Allowable Concentration; Metabolic Clearance Rate; Nanotechnology; No-Observed-Adverse-Effect Level; Occupational Exposure; Rats; Risk Assessment	2011

Article

Year

Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level.

Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 123, Issue:2

Topics: Animals; Dose-Response Relationship, Drug; Fullerenes; Humans; Inhalation Exposure; Intubation, Intratracheal; Lung; Lung Diseases; Maximum Allowable Concentration; Metabolic Clearance Rate; Nanotechnology; No-Observed-Adverse-Effect Level; Occupational Exposure; Rats; Risk Assessment

2011

Other Studies

5 other study(ies) available for fullerene c60 and Lung Diseases

Article	Year
Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicology and applied pharmacology, 2010, Apr-15, Volume: 244, Issue:2 Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Cycle; Fullerenes; Inflammation Mediators; Lung; Lung Diseases; Male; Mice; Mice, Inbred ICR; Particle Size	2010
A Two-Pronged Pulmonary Gene Delivery Strategy: A Surface-Modified Fullerene Nanoparticle and a Hypotonic Vehicle. Angewandte Chemie (International ed. in English), 2021, 07-05, Volume: 60, Issue:28 Topics: Chronic Disease; Epoxy Compounds; Fullerenes; Gene Transfer Techniques; Humans; Lung Diseases; Nanoparticles	2021
Fullerene derivatives protect against oxidative stress in murine macrophage line cells and ischemia-reperfused lungs. American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Volume: 287, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Pressure; Cell Line; Fullerenes; Lung Diseases; Macrophages; Mice; Oxidative Stress; Reperfusion Injury	2004
Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Volume: 287, Issue:1 Topics: Animals; Antioxidants; Capillary Permeability; Cell Line; Cell Survival; Fullerenes; Hydrogen Peroxide; In Vitro Techniques; Lung Diseases; Macrophages; Male; Membrane Potentials; Mice; Nitric Oxide Donors; Nitroprusside; Oxidants; Oxidative Stress; Pulmonary Circulation; Pulmonary Wedge Pressure; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury	2004
Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano letters, 2007, Volume: 7, Issue:8 Topics: Animals; Carboxylic Acids; Colloids; Dose-Response Relationship, Drug; Fullerenes; Lung; Lung Diseases; Materials Testing; Nanoparticles; Rats; Solubility; Water	2007